Royalty Pharma Sub-Manager, LLC: 13F holdings
CIK 20816682026Q2
| Positions | 4 |
|---|---|
| Reported value | $241.9m |
| Filed | 2026-08-21 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| CYTK CYTOKINETICS, INC | 980,392 | $83.5m | 34.5% |
| ZENAS BIOPHARMA, INC. | 2,388,150 | $60.6m | 25.1% |
| KAILERA THERAPEUTICS | 2,455,357 | $54.1m | 22.4% |
| BIOHAVEN LTD | 2,936,507 | $43.7m | 18.1% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="2081668")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.